Zacks Investment Research on MSN3h
JD.com Rises 49% in a Year: Should Investors Buy the Stock Now?
JD.com JD shares have returned 48.7% in the trailing 12-month period, outperforming the Zacks Retail-Wholesale sector and the S&P 500 index’s growth of 12.5% and 8.2%, respectively. The stock has also ...
Could buying these growth stocks today be like buying Amazon or Apple 10 years ago?
If someone’s looking for growth stocks with tons of potential, the cybersecurity sector could be a good place to start, says ...
US Tariffs on Pharma: Zydus, Dr Reddy’s at highest risk, says Jefferies; Check impact on other Indian pharma stocks
Given Zydus Lifesciences and Dr Reddy’s Laboratories have high US sales exposure with ~45% and 43% sales contribution, ...